hexaox - CAS号查询

N,N'-(5,13,14,15,20,28,29,30-octahydro-5,13,15,20,28,30-hexaoxobenzo[4,5]naphth[2''',3'''：6Benzamid;
benzamide, n,n'-(5,13,14,15,20,28,29,30-octahydro-5,13,15,20,28,30-hexaoxobenzo-[4,5]naphth[2''',3'''：6'',7'']indolo[3'',2''：4',5']aceanthryleno[1',2'：2,3]inde;
1-ab]naphtho[2,3-i]carbazole-4,19-diyl)bis-no[Benzamide,N,N'-(5,13,14,15,20,28,29,30-octahydro-5,13,15,20,28,30-hexaoxobenzo[4,5]naphth[2''',3'''：6'',7'']indolo[3'',2''：4',5']

C72H34N4O8

详情

供应商

2615-15-8

六聚乙二醇;
六甘醇;
六乙二醇;
硫乙烯基乙二醇

hexaoxyethylene glycol;
3,6,9,12,15-Pentaoxaheptadecane-1,17-diol;
hexa(ethylene glycol)

Amphotericin B,16-decarboxy-16-(1-oxo-5,8,11,14,17,20-hexaoxa-2-azaheneicos-1-yl)- (9CI);
AntibioticKY 62

氧化钒铜(II)

copper divanadium hexaoxide;
copper(ii) vanadium oxide;
copper vanadate;
copper (ii) metavanadate;
cupric metavanadate;
cupric vanadate;
copper divanadium hexaoxide;
99.7%min(metalsbasis),typically99.9%(metalsbasis);
copper(ii) vanadium oxide, 99.7% min (metals basis), typically 99.9% (metals basis)

Cereulide (9CI);
1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl-D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl-D-alanyl-3-methyl-L-2-hydroxybutanoyl-L-valyl-4-methyl-D-2-hydroxypentanoyl)

Cyclohexasiloxane;
1,3,5,7,9,11-hexaoxa-2,4,6,8,10,12-hexasilacyclododecane

4-硝基苯并-18-冠-6醚

Dibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin,6,7,9,10,17,18,20,21-octahydro-2-nitro-;
4'-Nitrodibenzo-18-crown-6

Dodecanoic acid,20-hydroxy-3,6,9,12,15,18-hexaoxaeicos-1-yl ester;
Lauricacid, monoester with heptaethylene glycol (8CI);
Heptaethylene glycol,monolaurate (8CI)

Dibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin,2,13(or 2,14)-bis(1,1-dimethylethyl)eicosahydro-;
4,4'(5')-Bis(tert-butylcyclohexano)-18-crown-6;
4,4'(5')-[Di-tert-butyldicyclohexano]-18-crown-6;
4,4',(5')-di(t-butyldicyclohexano)-18-crown-6;
D(Me3C)CH18C6

enantio-Valinomycin(8CI,9CI);
1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl-L-a-hydroxyisovaleryl-L-valyl-D-lactoyl-D-valyl)

enantio-pseudo-retro-Valinomycin(8CI,9CI);
1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl);
Cyclo(D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl-D-a-hydroxyisovaleryl-D-alanyl-L-a-hydroxyisovaleryl-L-valyl)

enantio-retro-Valinomycin(8CI,9CI);
1,7,13,19,25,31-hexaoxa-4,10,16,22,28,34-hexaazacyclohexatriacontane,cyclic peptide deriv.;
Cyclo(L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl-L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl-L-a-hydroxyisovaleryl-D-valyl-D-lactoyl-L-valyl)